AbbVie Raises FY2026 Adj EPS Guidance from $13.96-$14.16 to $14.08-$14.28 vs $14.12 Est

Benzinga Newsdesk www.benzinga.com Positive 94.0%

Neg 0% Neu 0% Pos 94%

AbbVie (NYSE:ABBV) raises FY2026 Adj EPS guidance from $13.96-$14.16 to $14.08-$14.28 vs $14.12 analyst estimate..

Comments

No comments yet. Be the first!